This is an open-label, multi-center study to evaluate the safety, tolerability, and anti-tumor activity of SNK01 in combination with AFM24 in subjects with advanced or metastatic EGFR-expressing cance
People living with cancer have a profound need to understand any potential negative impacts of treatment on their everyday lives and whether the treatment itself could cause other long-term health cha
